Sacituzumab Govitecan in Metastatic Colorectal Cancer

Clinical trial NCT06243393 · RECRUITING

Trial details

NCT number: NCT06243393
Sponsor: University Hospital Heidelberg
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2024-04-19
Primary completion: 2028-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.